ORMP icon

Oramed Pharmaceuticals
ORMP

Overview Fund Activity

46 hedge funds and large institutions have $16.2M invested in Oramed Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 14 reducing their positions, and 9 closing their positions.

Holders
46
Holders Change
-6
Holders Change %
-11.54%
% of All Funds
0.62%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
4
Increased
8
Reduced
14
Closed
9
Calls
$231K
Puts
–
Net Calls
+$231K
Net Calls Change
+$209K

Top Buyers

1
Citadel Advisors
1
Citadel Advisors
Florida
$196K
2
BCM
2
BML Capital Management
Indiana
$6.94M
3
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$376K
4
Mariner
4
Mariner
Kansas
$22.7K
5
Wealth Enhancement Advisory Services
5
Wealth Enhancement Advisory Services
Minnesota
$41K

Top Sellers

1
Two Sigma Advisers
1
Two Sigma Advisers
New York
$0
2
PLC
2
Peapod Lane Capital
New York
$191K
3
Two Sigma Investments
3
Two Sigma Investments
New York
$0
4
Royal Bank of Canada
4
Royal Bank of Canada
Ontario, Canada
$107K
5
Connor, Clark & Lunn Investment Management (CC&L)
5
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$136K
Name Market Value Shares Shares
Change 		Shares
Change %
PCM
51
Prelude Capital Management
New York
– – -13,435 Closed
Simplex Trading
52
Simplex Trading
Illinois
– – -7,244 Closed
Group One Trading
53
Group One Trading
Illinois
– – -3,310 Closed
FHA
54
First Horizon Advisors
Tennessee
– – -1,750 Closed
TRCT
55
Tower Research Capital (TRC)
New York
– – -649 Closed
1 2
3